240 related articles for article (PubMed ID: 9335067)
1. Molecular characteristics of mammalian dopamine receptors.
Lachowicz JE; Sibley DR
Pharmacol Toxicol; 1997 Sep; 81(3):105-13. PubMed ID: 9335067
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors.
Dahmer MK; Senogles SE
J Neurochem; 1996 Jan; 66(1):222-32. PubMed ID: 8522958
[TBL] [Abstract][Full Text] [Related]
3. Dopamine induces a biphasic modulation of hypothalamic ANF neurons: a ligand concentration-dependent effect involving D5 and D2 receptor interaction.
Lee D; Huang W; Lim AT
Mol Psychiatry; 2000 Jan; 5(1):39-48. PubMed ID: 10673767
[TBL] [Abstract][Full Text] [Related]
4. Roles of dopamine receptor subtypes in mediating modulation of T lymphocyte function.
Huang Y; Qiu AW; Peng YP; Liu Y; Huang HW; Qiu YH
Neuro Endocrinol Lett; 2010; 31(6):782-91. PubMed ID: 21196914
[TBL] [Abstract][Full Text] [Related]
5. Functional and autoradiographic characterization of dopamine D2-like receptors in the guinea pig heart.
Gómez Mde J; Rousseau G; Nadeau R; Berra R; Flores G; Suárez J
Can J Physiol Pharmacol; 2002 Jun; 80(6):578-87. PubMed ID: 12117307
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the binding of SCH 39166 to the five cloned dopamine receptor subtypes.
Tice MA; Hashemi T; Taylor LA; Duffy RA; McQuade RD
Pharmacol Biochem Behav; 1994 Nov; 49(3):567-71. PubMed ID: 7862709
[TBL] [Abstract][Full Text] [Related]
7. Chimeric D1/D2 dopamine receptors. Distinct determinants of selective efficacy, potency, and signal transduction.
Kozell LB; Machida CA; Neve RL; Neve KA
J Biol Chem; 1994 Dec; 269(48):30299-306. PubMed ID: 7982941
[TBL] [Abstract][Full Text] [Related]
8. Dopamine D4-like receptors in vertebrate retina: does the retina offer a model for the D4-receptor analysis?
Zawilska JB; Nowak JZ
Pol J Pharmacol; 1997 Aug; 49(4):201-11. PubMed ID: 9437763
[TBL] [Abstract][Full Text] [Related]
9. Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors.
Perachon S; Schwartz JC; Sokoloff P
Eur J Pharmacol; 1999 Feb; 366(2-3):293-300. PubMed ID: 10082211
[TBL] [Abstract][Full Text] [Related]
10. Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1.
Sunahara RK; Guan HC; O'Dowd BF; Seeman P; Laurier LG; Ng G; George SR; Torchia J; Van Tol HH; Niznik HB
Nature; 1991 Apr; 350(6319):614-9. PubMed ID: 1826762
[TBL] [Abstract][Full Text] [Related]
11. The psychopharmacology-molecular biology interface: exploring the behavioural roles of dopamine receptor subtypes using targeted gene deletion ('knockout').
Waddington JL; Clifford JJ; McNamara FN; Tomiyama K; Koshikawa N; Croke DT
Prog Neuropsychopharmacol Biol Psychiatry; 2001 May; 25(4):925-64. PubMed ID: 11383985
[TBL] [Abstract][Full Text] [Related]
12. Studying the dopaminergic system with transfected receptors.
Yamaguchi I; Walk SF; Felder RA
Hypertens Res; 1995 Jun; 18 Suppl 1():S19-22. PubMed ID: 8529058
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in dopamine receptors: what do they tell us?
Wong AH; Buckle CE; Van Tol HH
Eur J Pharmacol; 2000 Dec; 410(2-3):183-203. PubMed ID: 11134669
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of a chimeric hD3/D2 dopamine receptor expressed in CHO cells.
McAllister G; Knowles MR; Patel S; Marwood R; Emms F; Seabrook GR; Graziano M; Borkowski D; Hey PJ; Freedman SB
FEBS Lett; 1993 Jun; 324(1):81-6. PubMed ID: 8099332
[TBL] [Abstract][Full Text] [Related]
15. D1A, D1B, and D1C dopamine receptors from Xenopus laevis.
Sugamori KS; Demchyshyn LL; Chung M; Niznik HB
Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10536-40. PubMed ID: 7937989
[TBL] [Abstract][Full Text] [Related]
16. Dopamine receptor coupling to adenylyl cyclase in rat olfactory pathway: a combined pharmacological-radioautographic approach.
Coronas V; Krantic S; Jourdan F; Moyse E
Neuroscience; 1999 Apr; 90(1):69-78. PubMed ID: 10188934
[TBL] [Abstract][Full Text] [Related]
17. Dopamine receptor multiplicity: "D1-like'-"D2-like' interactions and " D1-like" receptors not linked to adenylate cyclase.
Waddington JL; Deveney AM
Biochem Soc Trans; 1996 Feb; 24(1):177-82. PubMed ID: 8674655
[No Abstract] [Full Text] [Related]
18. In vitro pharmacological profile of YM-43611, a novel D2-like receptor antagonist with high affinity and selectivity for dopamine D3 and D4 receptors.
Hidaka K; Tada S; Matsumoto M; Ohmori J; Tasaki Y; Nomura T; Usuda S; Yamaguchi T
Br J Pharmacol; 1996 Apr; 117(8):1625-32. PubMed ID: 8732269
[TBL] [Abstract][Full Text] [Related]
19. Striatal gene expression of RGS2 and RGS4 is specifically mediated by dopamine D1 and D2 receptors: clues for RGS2 and RGS4 functions.
Taymans JM; Leysen JE; Langlois X
J Neurochem; 2003 Mar; 84(5):1118-27. PubMed ID: 12603835
[TBL] [Abstract][Full Text] [Related]
20. Dopamine-opioid interactions in the rat striatum: a modulatory role for dopamine D1 receptors in delta opioid receptor-mediated signal transduction.
Unterwald EM; Cuntapay M
Neuropharmacology; 2000 Jan; 39(3):372-81. PubMed ID: 10698003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
